Clinical Trials Directory

Trials / Unknown

UnknownNCT03290690

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds

Status
Unknown
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
MolecuLight Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.

Conditions

Timeline

Start date
2017-08-04
Primary completion
2020-07-30
Completion
2020-07-30
First posted
2017-09-25
Last updated
2020-03-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03290690. Inclusion in this directory is not an endorsement.

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa (NCT03290690) · Clinical Trials Directory